SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is seeing renewed momentum driven by strong prescription data and positive sentiment surrounding the oral Wegovy rollout, which is being viewed as a strategic advantage against competitors. Investors are closely watching the upcoming earnings report, with community discussions heavily focused on the company's ability to maintain its market position through potential M&A and improved guidance.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is seeing significant momentum and retail interest as investors connect the company's specialized MRAM technology to broader AI memory and aerospace growth narratives. Market participants are actively debating the sustainability of this rapid move, with bulls pointing to recent defense contracts and low float as catalysts for a potential squeeze, while some skeptics express concerns over high valuations and technical resistance.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is currently experiencing heightened retail activity and speculative momentum driven by its integration into the broader Japanese blockchain and IoT data economy narratives. While the community is actively debating the potential impact of ecosystem expansions like Janction, sentiment remains divided between long-term holders accumulating positions and skeptics focused on historical price underperformance.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF (SOXX) is trending as traders debate whether its parabolic rise represents a sustainable AI-driven supercycle or a speculative bubble reminiscent of the dot-com era. Community discussions are dominated by the ongoing tug-of-war between aggressive bulls targeting further highs and cautious investors citing record-high RSI levels and potential overvaluation, leading to intense debates over hedging strategies and the timing of a possible correction.

Investment Managers Series Trust II - Tradr 2X Short SNDK Daily ETF

Tradr 2X Short SNDK Daily ETF

Tradr 2X Short SNDK Daily ETF (SNDQ) is seeing significant volume and trader attention as market participants attempt to hedge against the rapid, parabolic price appreciation in SanDisk (SNDK). The community is actively debating the sustainability of the semiconductor sector's momentum, with many users employing SNDQ as a tactical vehicle to bet on a potential correction or reversal.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending following a corporate update regarding financial results and the company's progress toward a pivotal Phase 3 clinical trial for its lead candidate, CAD-1005, aimed at treating heparin-induced thrombocytopenia. While some community members are optimistic about the upcoming trial registration path and orphan drug designations, others are expressing skepticism, focusing on potential share dilution and concerns over aggressive social media promotion.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as shareholders react to reports that FDA Commissioner Marty Makary may be replaced, a move widely interpreted by the community as a positive catalyst that could alleviate regulatory friction for the company's oncology pipeline. Investors are actively discussing the potential for smoother sBLA reviews and increased global expansion, fueling bullish sentiment despite recent volatility and ongoing legal disputes.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is currently facing significant volatility as investors weigh strong quarterly revenue and earnings beats against concerns over lowered forward guidance and broader fears that AI agents could disrupt the traditional SaaS business model. The community remains deeply divided, with some investors aggressively buying the dip due to the company's strong cash position and growth metrics, while others warn of potential further downside fueled by intense short-selling pressure and skepticism regarding long-term software viability in an AI-native market.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Abbott Laboratories

Abbott Laboratories is experiencing significant downward pressure as investors weigh disappointing earnings guidance and the financial implications of its recent acquisition of Exact Sciences. The community is actively debating whether the current price levels represent a deep-value buying opportunity or a value trap amid ongoing litigation concerns and broader institutional de-risking within the healthcare sector.

The Internet Computer is a decentralized cloud blockchain designed to run applications, websites, and backend systems fully on-chain. Its architecture provides robust security, resilience, and built-in multi-chain support.  A key focus of the network is enabling a “self-writing cloud,” where AI tools allow users generate applications through natural-language instructions.  Developers and users can experiment with the platform using AI app-generation tools like caffeine.ai or by writing serverless code directly through online IDEs such as icp.ninja.  The ICP token is used to pay for computation (through a burn-based model) and to participate in network governance through staking.

Internet Computer

Internet Computer (ICP) is currently a focal point for investors debating its long-term infrastructure value versus its recent price volatility, with community sentiment split between frustration over performance and optimism surrounding its sovereign cloud capabilities and ongoing network burn. Discussions are dominated by speculation about future government partnerships and the impact of tokenomic updates, as traders monitor whether it can maintain structural support levels amidst broader market pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Federal Agricultural Mortgage (AGM) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is NewtekOne, Inc. (NEWT) Outperforming Other Finance Stocks This Year?

Here is how NewtekOne (NEWT) and Federal Agricultural Mortgage (AGM) have performed compared to their sector so far this year.

Federal Agricultural Mortgage Q1 Earnings Call Highlights

Federal Agricultural Mortgage (NYSE:AGM) reported what executives repeatedly characterized as a record-setting start to fiscal 2026, citing all-time highs in business volume, quarterly revenue and quarterly core earnings during its first-quarter earnings call.

Record quarter driven by volume growth...

Federal Agricultural Mortgage (AGM) Q1 Earnings Surpass Estimates

Farmer Mac (AGM) delivered earnings and revenue surprises of +4.98% and -0.77%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Federal Agricultural Mortgage (NYSE:AGM) Posts Earnings Results, Beats Expectations By $0.30 EPS

Federal Agricultural Mortgage (NYSE:AGM - Get Free Report) announced its earnings results on Tuesday. The credit services provider reported $4.74 EPS for the quarter, beating the consensus estimate...

Farmer Mac Reports First Quarter 2026 Results

Farmer Mac Reports First Quarter 2026 Results Farmer Mac Reports First Quarter 2026 Results PR Newswire WASHINGTON, May 5, 2026 - Outstanding Business Volume of $34.8 Billion -WASHINGTON, May 5, 2026...

VELA Investment Management LLC Sells 12,247 Shares of Federal Agricultural Mortgage Corporation $AGM

VELA Investment Management LLC trimmed its position in Federal Agricultural Mortgage Corporation (NYSE:AGM - Free Report) by 78.8% in the fourth quarter, according to its most recent Form 13F filing...

Federal Agricultural Mortgage Corporation (NYSE:AGM) Short Interest Down 15.0% in April

Federal Agricultural Mortgage Corporation (NYSE:AGM - Get Free Report) saw a large decline in short interest in April. As of April 15th, there was short interest totaling 366,391 shares, a decline of 15.0% from the March 31st total of 430,997 shares. Based on an average daily volume of 88,757...

Federal Agricultural Mortgage (AGM) Projected to Post Quarterly Earnings on Tuesday

Federal Agricultural Mortgage (NYSE:AGM) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-5-federal-agricultural-mortgage-co-stock...

Copeland Capital Management LLC Sells 13,312 Shares of Federal Agricultural Mortgage Corporation $AGM

Copeland Capital Management LLC lessened its stake in shares of Federal Agricultural Mortgage Corporation (NYSE:AGM - Free Report) by 5.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 240,905 shares of the credit servi...

Federal Agricultural Mortgage Corp. is a stockholder-owned, federally chartered corporation, which engages in the provision of a secondary market for a variety of loans made to borrowers in rural America. It operates through the following segments: Farm and Ranch, Corporate AgFinance, Power and Utilities, Broadband Infrastructure, Renewable Energy, Funding, and Investments. The Farm and Ranch segments includes the USDA Securities portfolio, Farm and Ranch loans, and AgVantage securities. The Corporate AgFinance segment focuses on loans and AgVantage securities to larger and more complex farming operations, agribusinesses focused on food and fiber processing, and other supply chain production. The Power and Utilities segment refers to the loans to rural electric generation and transmission cooperatives, and distribution cooperatives. The Broadband Infrastructure segment represents the loans to rural fiber, cable and broadband, tower, wireless, local exchange carrier, and data center projects. The Renewable Energy segment is involved in the rural electric solar, wind, and gas projects. The Funding segment consists of debt issuance, hedging, asset and liability management, and capital allocation strategies. The Investments segment provides a financial result of the investment portfolio, which is held for liquidity purposes. The company was founded in 1987 and is headquartered in Washington, DC.

Federal Agricultural Mortgage Corp. - Ordinary Shares - Class C

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

AGM
Federal Agricultural Mortgage Corp. - Ordinary Shares - Class C

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest AGM News

AGMFederal Agricultural Mortgage Corp. - Ordinary Shares - Class C